BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 18598135)

  • 1. Malonyl-CoA, a key signaling molecule in mammalian cells.
    Saggerson D
    Annu Rev Nutr; 2008; 28():253-72. PubMed ID: 18598135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of genes regulating malonyl-CoA in human skeletal muscle.
    Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
    J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
    Onay-Besikci A; Sambandam N
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
    Folmes CD; Lopaschuk GD
    Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.
    Peluso G; Petillo O; Margarucci S; Grippo P; Melone MA; Tuccillo F; Calvani M
    J Cell Physiol; 2005 May; 203(2):439-46. PubMed ID: 15515015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine palmitoyltransferase I (CPT I) activity and its regulation by malonyl-CoA are modulated by age and cold exposure in skeletal muscle mitochondria from newborn pigs.
    Schmidt I; Herpin P
    J Nutr; 1998 May; 128(5):886-93. PubMed ID: 9566999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
    Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
    Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malonyl-CoA, fuel sensing, and insulin resistance.
    Ruderman NB; Saha AK; Vavvas D; Witters LA
    Am J Physiol; 1999 Jan; 276(1):E1-E18. PubMed ID: 9886945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
    Velasco G; Geelen MJ; Guzmán M
    Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
    Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an anaplerotic/malonyl-CoA pathway in pancreatic beta-cell nutrient signaling.
    Brun T; Roche E; Assimacopoulos-Jeannet F; Corkey BE; Kim KH; Prentki M
    Diabetes; 1996 Feb; 45(2):190-8. PubMed ID: 8549864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
    Alam N; Saggerson ED
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
    Zhou L; Huang H; Yuan CL; Keung W; Lopaschuk GD; Stanley WC
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H954-60. PubMed ID: 18083904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malonyl-CoA and AMP-activated protein kinase: an expanding partnership.
    Saha AK; Ruderman NB
    Mol Cell Biochem; 2003 Nov; 253(1-2):65-70. PubMed ID: 14619957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
    Cha SH; Hu Z; Chohnan S; Lane MD
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy.
    Lewandowski ED; Fischer SK; Fasano M; Banke NH; Walker LA; Huqi A; Wang X; Lopaschuk GD; O'Donnell JM
    Circ Res; 2013 Jan; 112(1):57-65. PubMed ID: 22982985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus.
    Shafrir E; Ziv E; Saha AK; Ruderman NB
    Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.